Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study

Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: A randomized, double-blind, crossover study in healthy adult subjects

(2009) Catherine Datto et al.   CLINICAL THERAPEUTICS

Efficacy of Quetiapine Monotherapy for the Treatment of Depressive Episodes in Bipolar I Disorder

(2009) Richard H. Weisler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression

(2009) Madhukar H. Trivedi et al.   JOURNAL OF CLINICAL PSYCHIATRY

Rapid Onset of Antidepressant Action

(2009) Rodrigo Machado-Vieira et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder

(2009) Michael Bauer et al.   JOURNAL OF CLINICAL PSYCHIATRY

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder

(2009) Andrew J. Cutler et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antipsychotic-Induced Extrapyramidal Side Effects in Bipolar Disorder and Schizophrenia

(2009) Keming Gao et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts

(2008) R. T. Mulder et al.   ACTA PSYCHIATRICA SCANDINAVICA

P.2.g.008 Extended release quetiapine fumarate monotherapy as maintenance treatment in patients with major depressive disorder (MDD)

(2008) C. Datto et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Sleep problems and suicidality in the National Comorbidity Survey Replication

(2008) Marcin Wojnar et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release

(2008) Carlos Figueroa et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

(2007) George I. Papakostas et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY